None of them come close to matching the weight loss results of pharmaceutical GLP-1 agonists
People using GLP-1a weight loss and diabetes medications, such as Ozempic and Mounjaro, experience a dramatic slowdown in their intestinal transit time down to just a fifth of the usual rate
Nevertheless, out of the 1157 plasma metabolites assessed, we did not identify any discriminatory metabolite or group of metabolites that could serve as a biomarker on its own
Smaller trials in volunteers with insomnia also report a favorable safety profile and no side effects during or after DSIP administration [6]
Let me walk you through whats real, whats still early, and how to think about it honestly
However, other factors may be involved, including accumulation of lactate, pyruvate, glutamine and free glucose, and depletion of glycogen, ketone bodies and glutamate